We hear that all the time.  That’s a common misconception. While it’s true tinnitus cannot be cured, it can be treated and managed effectively. We have an 85% success rate at reducing or even eliminating the perception of tinnitus.

We create a customized treatment plan for each patient based on the results of our tinnitus evaluation. This may include the Lenire device, hearing technology, and / or the use of our 9 week adaptation program called My Tinnitus Therapy.

Lenire (Len-ear), which is Latin for ‘soothe’, is the only commercially available, clinically trialed, dual mode tinnitus treatment device approved by the US FDA. It works using bimodal neuromodulation, which is the stimulation of not one but two nerves at the same time. With Lenire, for example, you have the combination of electrical stimulation via the tongue as well as auditory stimulation via the ear. Research has suggested that the combined stimulation of these two nerves drives stronger adaptive neuroplasticity, which in turn can reduce the brain’s attention and sensitivity to the tinnitus sound to a greater extent than when stimulating only a single nerve at a time.

It depends on what treatment is prescribed. For example, a twelve month treatment plan with Lenire (including the consultation, digital therapeutics, the custom-programmed device, monitoring and follow up care) is $375 per month (OAC). If hearing devices are prescribed, those treatment plans are generally 48 months at $169-$219 per month, depending on needs. The initial consultation is complimentary and treatment recommendations and options will be provide at that time based on the results of our testing.

This will depend on the results of our initial examination. If the exam reveals that your tinnitus is caused by hearing loss, your provider will recommend a treatment plan using hearing aids and/or Lenire therapy.

While some people experience almost immediate relief, for many others, it can take 6 weeks-12 months of following the treatment plan to achieve the desired results. During your treatment appointment, your provider will help you set some goals and milestones and during your follow-up appointments, those treatment goals will be discussed and evaluated. If a revision to your treatment plan is necessary to achieve your goals, your provider will discuss those options with you at that time.

We get it. It can seem like a lot to commit to treatment before you've tried other options. We created My Tinnitus Therapy ideally to be used with specially programmed hearing aids or with Lenire, but it has helped many people as a stand-alone treatment. It is a 9 week online course that teaches you tinnitus adaptation tools using audiological counseling and cognitive behavioral therapy. The course is normally $399, but using the code 'tinnitus25", you can get 25% off. You can also click here to get the offer.

No medical treatment can be promised as a "sure thing". But here’s the good news: when patients follow their tinnitus treatment plan, more than 85% see meaningful improvement. To put that in perspective, that’s a higher success rate than blood pressure medication—one of the most common prescriptions in America

If you have hearing loss along with the tinnitus, some insurance companies will cover a percentage of the hearing aids we use for our treatment plans. Currently we know of no insurance company covering the cost of Lenire. We do have a no-interest 12 month payment plan (OAC) for those who qualify. You may be able to use your HSA or Flex-spending benefits to purchase the device. To make treatment more affordable, we offer monthly payment plans on approved credit.

Lenire has been proven as a safe and effective tinnitus treatment in clinical trials with more than 600 participants.

TENT-A1 (Trial 1): This study showed that 86.2% of treatment compliant participants reported an improvement in their THI score after 12 weeks of treatment. 80.1% reporting improvement that sustained for 12 months after treatment.

TENT-A2 (Trial 2): 91%of compliant patients had sustained relief from tinnitus that lasted 12-months. The average reduction in tinnitus was 20.3 THI points, equal to a full THI grade.

TENT-A3 (Trial 3): Lenire has been proven to be more effective than sound-alone for the majority of people with moderate or worse tinnitus.

All Trials: Across all clinical trials, 83% would recommend Lenire to treat tinnitus.

Lenire also conducted real world trials with more than 200 people. The results of Lenire’s real world trials closely matched clinical trial results.

Lenire is intended to treat patients 18 years of age and older suffering from at least moderate, subjective tinnitus.

The Lenire device is contraindicated for persons:

Who have a pacemaker, defibrillator or any other active implantable device, unless directed by a physician.

Who are pregnant, unless directed by a physician.

Who suffer from epilepsy or any other condition that may

result in loss of consciousness, unless directed by a physician.

Who suffer from any condition that causes impaired sensitivity of the tongue, unless directed by a physician or dentist.

Who have lesions, sores, or inflammation of the oral cavity that could be in contact with the Tonguetip (i.e., tip of tongue and lip area), unless directed by a physician or dentist.

Who are suffering from any intermittent or chronic neuralgia in the head and neck area, unless directed by a physician.

Who have tinnitus caused by Meniere’s disease, unless directed by a physician. The use of this device has not been evaluated in the TENT clinical studies for Meniere’s disease.

Who have tinnitus confirmed to be from an objective source.

Who have oral piercings present.